Gilead Sciences will open the doors to the company's new operations site in North Raleigh, N.C., as part of a business services center expansion. Gilead’s second-quarter 2021...
The U.S. Food and Drug Administration expanded the emergency use authorization of Regeneron Pharmaceuticals Inc.'s Covid-19 antibody cocktail, enabling the combo therapy's use as a preventive...
As one of the founding execs and longtime chief medical officer at Betta Pharma, Fenlai Tan isn’t just well aware of the allure of a me-better...
N-Dimethyltryptamine, or DMT, has experienced a recent surge in popularity in mental health and wellness communities. The naturally occurring psychedelic’s ties to shamanic practices and its...
Cell and gene therapies (C&GTs) present opportunities to not only treat disease, but to restore function and improve disease management. Although the opportunities with C&GTs are...
Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here. The biotech IPO rush continues, as three more companies — Nuvalent,...
The teams at Roche and Genentech are off and running at the FDA, with regulators accepting a quick pitch for what would be the first bispecific...
Officials at Cytiva and Pall, part of Danaher, will expand manufacturing capacity and services across geographies for global life sciences customers. A $1.5 billion two-year investment,...
The company's digital therapy platform works to measure and improve someone’s ability to walk after they have experienced a neurologic injury or disease.
What a difference a quarter can make. Stinging from a dip in sales for I/O blockbuster Opdivo last quarter, Bristol Myers Squibb’s top checkpoint inhibitor turned...
Boehringer Ingelheim’s latecomer antibody therapy for COVID-19 has been side-lined, as the company focuses its attention on its The post Boehringer takes alteplase to phase 3...
A week after it was reported that India’s Covid-19 death toll could be in the millions, antibody legend Tillman Gerngross has inked a deal to develop...
The U.S. Food and Drug Administration issued Incyte Corporation with a Complete Response Letter (CRL) over the company's Biologics License Application (BLA) for retifanlimab for anal cancer.
In PerkinElmer's largest purchase ever, the Massachusetts-based company is dropping a massive $5.25 billion in cash and stock to buy the biomedical research tool company BioLegend.
Once vetted by the Biden team to lead the FDA as commissioner, Luciana Borio is now compiling quite the résumé. Borio has now been named a...
Simona King → Back in May, Passage Bio CFO Richard Morris and CMO Gary Romano left within days of each other, but this week the gene...
Which Robinhood penny stocks are on your watchlist next month? The post Top Penny Stocks on Robinhood For Your August 2021 Watchlist appeared first on Penny...
Credit: González Gutiérrez J., et al, Journal CHEST® Glenview, Ill. – Published monthly, the journal CHEST® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical...
Could virtual reality tools be effective in helping patients ‘unlearn’ their chronic pain? Professor Christopher Eccleston from the The post Virtual reality therapy: The future of...
The winners of Britain's Funniest Class contest show us that kids can be funny. But how early can they do it on purpose?
These hot penny stocks may deserve a place on your watchlist this month The post Hot Penny Stocks to Buy Now? 4 You Need to Know...
Congenica CEO David Atkins recently took time to chat with Clinical OMICs Editor in Chief Chris Anderson about the company’s plans and his views of the...
Clinical OMICs speaks to Jennifer Van Eyk, PhD, Director at Cedars Sinai Precision Biomarker Labs. The post Harnessing the Power of Proteomics to Advance Precision Medicine...
A new company based in the United Kingdom is interested in DMT’s potential for the treatment of depression. Small Pharma is the latest company to announce...
Investments in digital health firms are running high at the moment, and a $90 million round for four-year-old The post Digital mental health specialist Woebot raises...
Happify Health has launched a prescription digital therapeutic (DTx) – called Ensemble – that can assist the treatment The post Happify launches Ensemble DTx for depression,...
Phase 3 results with Roche’s amyloid-targeting Alzheimer’s drug gantenerumab may not be due until the second half of The post Roche ‘talking to FDA’ as Alzheimer’s...
What are the top NASDAQ genetics stocks year-to-date? We run through the five biggest gainers so far this year. The post Top NASDAQ Genetics Stocks appeared...
Novartis has revealed that the FDA has accepted its resubmission for cholesterol-lowering drug Leqvio – rejected unexpectedly by The post Novartis eyes New Year verdict from...
Last month, Mydecine Innovations Group (NEO: MYCO)(OTCMKTS: MYCOF) received a Buy” rating and C$3.00 price target from Roth Capital Partners, which represented a 916.94% premium to the...